Health Care Sector Performance: The S&P 500 Health Care Sector saw a significant gain of 9.1% in November, indicating a potential cyclical uptrend and a bullish outlook for 2026.
Medical Device Stocks: Notable breakouts in medical device stocks, such as IDEXX Laboratories and STERIS PLC, along with turnaround opportunities in GE Healthcare and Medtronic, suggest positive momentum in this segment.
iShares U.S. Medical Devices ETF (IHI): The IHI ETF shows a bullish cup-and-handle pattern and has recently broken above resistance, indicating a potential for new all-time highs and a strong performance in the coming months.
Long-Term Outlook: Despite a lower long-term trend compared to the S&P 500, signs of downside exhaustion in medical device stocks suggest improved performance relative to the broader market, supporting a positive outlook for 2026.
Wall Street analysts forecast IHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IHI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast IHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IHI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 61.850
Low
Averages
High
Current: 61.850
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
